Precigen Inc (PGEN)

Healthcare Biotechnology

6.50 $

-1.2% vs. previous close

Closing price · As of: 4. Aug 2026

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Income Statement PGEN
Tick rows to compare them in a chart (up to 4)	Q2 16	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	LTM
Revenue	0.44	0.41	0.39	0.45	0.45	0.38	0.64	0.34	0.35	0.25	0.33	0.15	0.23	0.15	0.05	0.19	0.19	0.14	0.11	0.02	0.02	0.02	0.02	0.03	0.01	0.08	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.07	0.10
Cost of Revenue	0.14	0.13	0.12	0.13	0.14	0.12	0.13	0.12	0.14	0.12	0.11	0.10	0.11	0.10	0.09	0.08	0.09	0.14	0.08	0.06	0.01	0.01	0.07	0.07	0.01	0.07	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.01	0.02
Gross Profit	0.30	0.29	0.27	0.32	0.31	0.26	0.51	0.22	0.21	0.13	0.22	0.05	0.12	0.05	-0.04	0.10	0.09	0.00	0.03	-0.04	0.01	0.01	-0.05	-0.04	0.01	0.01	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.07	0.08
Research & Development	0.24	0.25	0.24	0.29	0.28	0.30	0.32	0.29	0.33	0.35	2.13	0.22	0.22	0.20	0.02	0.07	0.06	0.06	0.02	0.05	0.07	0.06	0.06	0.06	0.06	0.06	0.05	0.05	0.05	0.05	0.05	0.06	0.06	0.04	0.04	0.03	0.04	0.04	0.02	0.02	0.11
Selling, General & Administrative	0.26	0.29	0.30	0.30	0.32	0.33	0.27	0.31	0.27	0.30	0.19	0.22	0.14	0.16	0.14	0.14	0.11	0.13	0.16	0.14	0.10	0.09	0.08	0.10	0.06	0.05	0.06	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.05	0.08	0.06	0.07	0.25
Total Operating Expenses	0.50	0.53	0.54	0.58	0.61	0.63	0.59	0.60	0.59	0.65	2.32	0.44	0.36	0.36	0.35	0.20	0.17	0.14	0.01	0.13	0.14	0.12	0.06	0.07	0.13	0.05	0.11	0.10	0.09	0.08	0.09	0.09	0.24	0.08	0.10	0.08	0.10	0.12	0.08	0.08	0.38
Operating Income	-0.20	-0.24	-0.27	-0.26	-0.29	-0.37	-0.22	-0.38	-0.38	-0.51	-2.56	-0.38	-0.24	-0.31	-0.38	-0.10	-0.07	-0.14	0.02	-0.17	-0.13	-0.11	-0.11	-0.11	-0.12	-0.04	-0.10	-0.10	-0.09	-0.08	-0.09	-0.10	-0.24	-0.08	-0.10	-0.08	-0.11	-0.12	-0.07	-0.02	-0.30
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.02
Pre-Tax Income	-0.43	-0.26	-0.38	-0.28	-0.17	-0.35	-0.29	-0.37	-0.53	-0.56	-2.61	-0.41	-0.26	-0.35	-0.34	-0.13	-0.10	-0.17	-0.01	-0.14	-0.16	-0.13	-0.13	-0.12	-0.13	-0.04	-0.11	-0.10	-0.08	-0.08	-0.13	-0.10	-0.24	-0.09	-0.07	-0.18	-0.09	-0.49	-0.08	-0.03	-0.65
Income Tax Expense	-0.01	0.00	0.00	0.00	-0.01	-0.01	-0.01	-0.03	-0.01	-0.11	-0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	0.60	0.00	–	–
Net Income	-0.42	-0.24	-0.37	-0.26	-0.16	-0.33	-0.23	-0.33	-0.51	-0.44	-2.59	-0.40	-0.25	-0.35	-1.09	-0.35	-0.26	-0.18	-0.23	-0.09	-0.10	-0.15	-0.13	-0.10	-0.09	0.44	-0.11	-0.10	-0.08	-0.08	-0.13	-0.10	-0.23	-0.09	-0.07	-0.18	-0.09	-0.49	-0.08	-0.03	-0.65
EBITDA	-0.20	-0.20	-0.32	-0.21	-0.11	-0.28	-0.22	-0.30	-0.46	-0.47	-2.52	-0.34	-0.19	-0.25	-0.27	-0.07	-0.04	-0.11	0.04	-0.10	-0.11	-0.09	-0.07	-0.10	-0.10	-0.02	-0.10	-0.09	-0.07	-0.07	-0.13	-0.09	-0.23	-0.08	-0.07	-0.18	-0.09	-0.49	-0.06	-0.01	-0.62

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings